|| All ER (D) 205 (Feb)
||Court of Justice of the European Union (Third Chamber)
Judges Lenaerts (President of the Chamber), Silva de Lapuerta (Rapporteur), Juhasz, Arestis and von Danwitz
||14 January 2010
European Union - Medicinal products - Transparency of measures regulating pricing of medicinal products for human use - Direct effect - Price freeze - Correct interpretation of relevant directive - Whether relevant directive involving only review as to whether healthcare expenditure manageable or whether extending to other macro-economic conditions - Whether following expiry of period for transposition of relevant directive provision of that directive to be considered to have direct effect - Council Directive (EEC) 89/105, art 4(1).
European Union Medicinal products. The Court of Justice of the European Union gave a preliminary ruling concerning the interpretation of art4(1) of Council Directive (EEC) 89-105 (relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems) in the context of actions brought by the applicant companies against the Belgian State in respect of measures adopted by the Belgian government freezing the prices of medicinal products.
- An Official transcript is the final version of the judgment prepared by shorthand writers. LexisLibrary contains all judgments from the High Court and aboveView Judgment
- The All England Law Reports comprises judgments with headnotes and catchwords indicating the area of law and key issues of the case prepared by legally qualified editorsFind AllER Reports
- Cases related to this particular case that are related to, or discuss this caseView related cases
- Commentary discussing this particular case from LexisLibrary's comprehensive range of titles including Butterworths, Halsbury's and TolleyView related commentary